Company Overview of Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. researches, develops, and manufactures pharmaceutical products for the treatment of a variety of cancer, gastrointestinal and metabolic conditions. The company was formerly known as Sapphire Therapeutics Inc. and changed its name to Helsinn Therapeutics (U.S.), Inc. in January, 2009. The company was founded in 2000 and is based in Iselin, New Jersey. As of January 28, 2009, Helsinn Therapeutics (U.S.), Inc. operates as a subsidiary of Helsinn Healthcare S.A.
170 Wood Avenue South
Iselin, NJ 08830
Founded in 2000
Key Executives for Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Helsinn Therapeutics (U.S.), Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.